Tobacco-related chronic illnesses: A public health concern for jamaica

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 9, 2012, Pages 4733-4738

  Crawford, Tazhmoye V ^a,c   McGrowder, Donovan D ^b   Barnett, Jasper D ^c   McGaw, Barbara A ^d   McKenzie, Irving F ^c   James, Leslie G ^c  

^a PAN AMERICAN HEALTH ORGANIZATION   (United States)

^b UNIVERSITY OF THE WEST INDIES   (Jamaica)

^c Ministry of Health   (Jamaica)

^d Heart Foundation of Jamaica   (Jamaica)

Author keywords

Consumption; Income; Jamaica.; Risks; Smoking; Tobacco

Indexed keywords

EID: 84874011326     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.9.4733     Document Type: Article

References (57)

1. Ahn C, Mulligan P, Salcido RS (2008). Smoking-the bane of wound healing: biomedical interventions and social influences. Adv Skin Wound Care, 21, 227-36.
2. Ayyagari P, Sindelar JL (2010). The impact of job stress on smoking and quitting: Evidence from the HRS. BEJ Econom Anal Policy, 10, 27.
3. Baig MR, Rajan M (2007). Effects of smoking on the outcome of implant treatment: a literature review. Effects of smoking on the outcome of implant treatment: a literature review. Indian J Dental Res, 18, 190-5.
4. Barnoya J, Glantz SA (2005). Cardiovascular effects of secondhand smoke: nearly as large as smoking. Circulation, 111, 2684-98.
5. Bauman KE, Foshee VA, Linzer MA, et al (1990). Effect of parental smoking classification on the association between parental and adolescent smoking. Addict Behav, 15, 413-22.
6. Begg S, Vos T, Goss J, et al (2007). The burden of disease and injury in Australia, 2003. Canberra: AIHW.
7. Bobak M, Jha P, Nguyen S, et al (2000). Poverty and smoking. In: Jha P, Chaloupka FJ, eds. Tobacco Control in Developing Countries, Section I, Chapter 3. Oxford: Oxford University Press.
8. Burke AP, Farb A, Malcom GT, et al (1997). Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med, 336, 1276-82.
9. Caponnetto P, Russo C, Polosa R (2012). Smoking cessation: present status and future perspectives. Curr Opin Pharmacol, 12, 229-37.
10. Castellsagué X, Díaz M, de Sanjosé S, et al (2006). Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst, 98, 303-15.
11. Centers for Disease Control and Prevention (2008). Smoking-attributable mortality, years of potential life lost, and productivity losses-United States, 2000-2004. Morbidity and Mortality Weekly Report, 57, 1226-1228. Accessed at http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm
12. Chapman S, Liberman J (2005). Ensuring smokers are adequately informed: reflections on consumer rights, manufacturer responsibilities, and policy implications. Tobacco Control, 14, 8-13.
13. Cheah YK, Naidu BM (2012). Exploring factors influencing smoking behaviour in malaysia. Asian Pac J Cancer Prev, 13, 1125-30.
14. Connolly GN, Alpert HR, Wayne GF, et al (2007). Trends in nicotine yield in smoke and its relationship with design characteristics among popular US cigarette brands, 1997-2005. Tob Control, 16, 5.
15. Denscombe M (2001). Uncertain identities and health-risking behaviour: the case of young people and smoking in late modernity. Br J Sociol, 52, 157-77.
16. Department of Health and Human Services (US) (1990). The health benefits of smoking cessation: a report of the surgeon general. Rockville (MD): Department of Health and Human Services, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. Available from: URL: http:// profiles.nlm.nih.gov/NN/B/B/C/T/
17. Dreyer L, Winther JF, Pukkala E, et al (1997). Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS, 76, 9-47.
18. Ezzati M, Lopez AD (2004). Regional, disease specific patterns of smoking-attributable mortality in 2000. Tobacco Control, 13, 388-95.
19. Gajalakshmi CK, Jha P, Ranson S, et al (2000). Global patterns of smoking and smokingattributable mortality. In: Jha P, Chaloupka F (eds), Tobacco control in developing countries. Oxford: Oxford University Press.
20. Geivelis M, Turner DW, Pederson ED, et al (1993). Measurements of interleukin-6 in gingival crevicular fluid from adults with destructive periodontal disease. J Periodontol, 64, 980-3.
21. Grief SN (2011). Nicotine dependence: health consequences, smoking cessation therapies, and pharmacotherapy. Prim Care, 38, 23-39.
22. Hashimoto Y (2011). Smoking and stroke. Brain Nerve, 63, 483-90.
23. Hill SE, Blakely T, Kawachi I, Woodward A (2007). Mortality among lifelong nonsmokers exposed to secondhand smoke at home: cohort data and sensitivity analyses. Am J Epidemiol, 165, 530-40.
24. Hosseinpoor AR, Parker LA, Tursan d'Espaignet E, et al (2011). Social determinants of smoking in low- and middle-income countries: Results from the World Health Survey. PLoS ONE, 6, 20331.
25. Huxley RR, Woodward M (2011). Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies. Lancet, 378, 1297-305.
26. Johnson GK, Slach NA (2001). Impact of tobacco use on periodontal health. J Dent Edu, 65, 313-21.
27. Kara I, Zysnarska M, Borkowicz M, et al (2009). Tobacco smoking among hospitalised patients with coronary arterial disease. Przegl Lek, 66, 727-8.
28. Kim J, Amar S (2006). Periodontal disease and systemic conditions: a bidirectional relationship. Odontology, 94, 10-21.
29. Kumar S, Prabu D, Kulkarni S, et al (2008). Tobacco as risk factor for periodontal disease in green marble mine laborers of Rajasthan, India. Brazilian J Oral Sci, 7, 1641-7.
30. Lee K, Gilmore A, Collin J (2004). Breaking and re-entering: British American Tobacco in China 1979-2000. Tobacco Control, 13, 88-95.
31. Memon A, Moody PM, Sugathan TN, et al (2000). Epidemiology of smoking among Kuwaiti adults: prevalence, characteristics, and attitudes. Bull World Hlth Organ, 78, 1306-15.
32. Mikelsone I, Bormane I, Simsone Z, et al (2011). The effect of chronic cigarette smoking on microvascular function, insulin resistance and inflammatory state. Environ and Exp Biology, 9, 23-8.
33. Moolgavkar SH, Holford TR, Levy DT, et al (2012). Impact of reduced tobacco smoking on lung cancer mortality in the United States during 1975-2000. J Natl Cancer Inst, 104, 541-8.
34. Mustapha IZ, Debrey S, Oladubu M, et al (2007). Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis. J Periodontol, 78, 2289-302.
35. National Toxicology Program (2008). Final report on carcinogens background document for styrene. Rep Carcinog Backgr Doc, 8, 398.
36. Office for National Statistics (1997). Teenage smoking attitudes in 1996. London: The Stationery Office.
37. Peto, R; Lopez AD, Boreham J, et al (2006). Mortality from smoking in developed countries 1950-2000: Indirect estimates from National Vital Statistics. Oxford University Press. http://www.ctsu.ox.ac.uk/~tobacco/.
38. Phommachanh B, Vang C (2007). The burden of chronic diseases detected in Mittaphab, Mahosot and Sethathirath Hospitals. Thesis for the degree of Doctor of Medicine. Faculty of Medical Sciences, National University of Laos.
39. Pierce JP, Gilpin EA (1996). How long will today's new adolescent smoker be addicted to cigarettes? Am J Public H lth, 86, 253-6.
40. Royal College of Physicians (1998). Health or smoking? Follow-up report of the Royal College of Physicans. London: Pitman Publishing.
41. Samet JM (2010). Estimating the burden of smoking: premature mortality, morbidity, and costs. Salud Publica Mex, 52, 98-107.
42. Siahpush M, Borland R, Scollo M (2003). Smoking and financial stress. Tob Control, 12, 60-6.
43. Singh GP, Rizvi I, Gupta V, et al (2011). Influence of smokeless tobacco on periodontal health status in local population of north India: A cross-sectional study. Dent Res J (Isfahan), 8, 211-20.
44. Stronks K, Van de Mheen HD, ONE AUTHOR, et al (1997). Cultural, material, and psychosocial correlates of the socioeconomic gradient in smoking behavior among adults. Prev Med, 26, 754-66.
45. Sunstein C (2000). In: Sunstein C, eds. Behavioural law and economics. Cambridge: Cambridge University Press.
46. Suomalainen K (1992). Relationship of collagenase and cathepsin G activity in gingival crevicular fluid. Scand J Dent Res, 100, 216-21.
47. United States Department of Health and Human Services (USDHHS) (1990). The health benefits of smoking cessation. A report of the Surgeon General. Washington, DC: US Government Printing Office.
48. US Department of the Treasury (1998). The economic costs of smoking in the United States and thebenefits of comprehensive tobacco legislation. Accessed at http://www.ustreas.gov/press/releases/reports/tobacco.pdf.
49. US Department of Health and Human Services (1982). The health consequences of smoking: Cancer. A Report of the Surgeon General. DHSS Publication PHS 82±50179. Washington, US Department of Health and Human Services.
50. Warren CW (2001). Tobacco use among youths: A cross country comparison: The Global Youth Tobacco Survey Collaborative Group.
51. Weinstein ND (2001). Smokers' recognition of their vulnerability to harm. In: Slovic P, ed. Smoking. Risk, perception and policy. Thousand Oaks, California: Sage Publications, p. 81-96.
52. West R, McEwen A, Bolling K, et al (2001). Smoking cessation and smoking patterns in the general population: a 1-year follow-up. Addiction, 96, 891-902.
53. Whitaker S, Hughes M (2003). Prevalence and influences on smoking in people with learning disabilities. Bri J Dev Disabilities, 49, 91-7.
54. Wipfli H, Samet JM (2009). Global economic and health benefits of tobacco control: part 1. Clin Pharmacol Ther, 86, 263-71.
55. World Bank (WB13429) (2001). M:\PH Fact Sheets\Latest Versions\tobacco at a glance.doc.
56. World Heath Organization (2005). Preventing chronic diseases - A vital investment. Available at http://www.who.int/chp/chronic_disease_report/en/.
57. World Health Organization International Agency for Research on Cancer, (1986). Tobacco smoking. IARC monograph on the evaluation of the carcinogenic risk of chemicals to humans. Lyon: IARC.